BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 23192222)

  • 1. Hypoxia, MTOR and autophagy: converging on senescence or quiescence.
    Blagosklonny MV
    Autophagy; 2013 Feb; 9(2):260-2. PubMed ID: 23192222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia suppresses conversion from proliferative arrest to cellular senescence.
    Leontieva OV; Natarajan V; Demidenko ZN; Burdelya LG; Gudkov AV; Blagosklonny MV
    Proc Natl Acad Sci U S A; 2012 Aug; 109(33):13314-8. PubMed ID: 22847439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Status of mTOR activity may phenotypically differentiate senescence and quiescence.
    Cho S; Hwang ES
    Mol Cells; 2012 Jun; 33(6):597-604. PubMed ID: 22570149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. mTOR Activity and Autophagy in Senescent Cells, a Complex Partnership.
    Cayo A; Segovia R; Venturini W; Moore-Carrasco R; Valenzuela C; Brown N
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia and gerosuppression: the mTOR saga continues.
    Leontieva OV; Blagosklonny MV
    Cell Cycle; 2012 Nov; 11(21):3926-31. PubMed ID: 22987149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weak p53 permits senescence during cell cycle arrest.
    Leontieva OV; Gudkov AV; Blagosklonny MV
    Cell Cycle; 2010 Nov; 9(21):4323-7. PubMed ID: 21051933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cordycepin inhibits cell senescence by ameliorating lysosomal dysfunction and inducing autophagy through the AMPK and mTOR-p70S6K pathway.
    Zuo SQ; Li C; Liu YL; Tan YH; Wan X; Xu T; Li Q; Wang L; Wu YL; Deng FM; Tang B
    FEBS Open Bio; 2021 Oct; 11(10):2705-2714. PubMed ID: 34448542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autophagy impairment with lysosomal and mitochondrial dysfunction is an important characteristic of oxidative stress-induced senescence.
    Tai H; Wang Z; Gong H; Han X; Zhou J; Wang X; Wei X; Ding Y; Huang N; Qin J; Zhang J; Wang S; Gao F; Chrzanowska-Lightowlers ZM; Xiang R; Xiao H
    Autophagy; 2017 Jan; 13(1):99-113. PubMed ID: 27791464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contact inhibition and high cell density deactivate the mammalian target of rapamycin pathway, thus suppressing the senescence program.
    Leontieva OV; Demidenko ZN; Blagosklonny MV
    Proc Natl Acad Sci U S A; 2014 Jun; 111(24):8832-7. PubMed ID: 24889617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The choice between p53-induced senescence and quiescence is determined in part by the mTOR pathway.
    Korotchkina LG; Leontieva OV; Bukreeva EI; Demidenko ZN; Gudkov AV; Blagosklonny MV
    Aging (Albany NY); 2010 Jun; 2(6):344-52. PubMed ID: 20606252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gerosuppression by pan-mTOR inhibitors.
    Leontieva OV; Blagosklonny MV
    Aging (Albany NY); 2016 Dec; 8(12):3535-3551. PubMed ID: 28077803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapamycin inhibits the secretory phenotype of senescent cells by a Nrf2-independent mechanism.
    Wang R; Yu Z; Sunchu B; Shoaf J; Dang I; Zhao S; Caples K; Bradley L; Beaver LM; Ho E; Löhr CV; Perez VI
    Aging Cell; 2017 Jun; 16(3):564-574. PubMed ID: 28371119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells.
    Qi M; Zhou H; Fan S; Li Z; Yao G; Tashiro S; Onodera S; Xia M; Ikejima T
    Eur J Pharmacol; 2013 Sep; 715(1-3):76-88. PubMed ID: 23810968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging.
    Menendez JA; Vellon L; Oliveras-Ferraros C; Cufí S; Vazquez-Martin A
    Cell Cycle; 2011 Nov; 10(21):3658-77. PubMed ID: 22052357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR-autophagy promotes pulmonary senescence through IMP1 in chronic toxicity of methamphetamine.
    Zhu MJ; Liu BY; Shi L; Wang X; Wang Y
    J Cell Mol Med; 2020 Oct; 24(20):12082-12093. PubMed ID: 32918374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interaction between mTOR pathway inhibition and autophagy induction attenuates adriamycin-induced vascular smooth muscle cell senescence through decreased expressions of p53/p21/p16.
    Sung JY; Lee KY; Kim JR; Choi HC
    Exp Gerontol; 2018 Aug; 109():51-58. PubMed ID: 28797827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spatio-temporal association between mTOR and autophagy during cellular senescence.
    Young AR; Narita M; Narita M
    Autophagy; 2011 Nov; 7(11):1387-8. PubMed ID: 21799306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trifluridine induces HUVECs senescence by inhibiting mTOR-dependent autophagy.
    Jia HJ; Zhou M; Vashisth MK; Xia J; Hua H; Dai QL; Bai SR; Zhao Q; Wang XB; Shi YL
    Biochem Biophys Res Commun; 2022 Jun; 610():119-126. PubMed ID: 35462092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knockdown of insulin-like growth factor 1 exerts a protective effect on hypoxic injury of aged BM-MSCs: role of autophagy.
    Yang M; Wen T; Chen H; Deng J; Yang C; Zhang Z
    Stem Cell Res Ther; 2018 Oct; 9(1):284. PubMed ID: 30359321
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Paradoxical suppression of cellular senescence by p53.
    Demidenko ZN; Korotchkina LG; Gudkov AV; Blagosklonny MV
    Proc Natl Acad Sci U S A; 2010 May; 107(21):9660-4. PubMed ID: 20457898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.